United Therapeutics Corp. (UTHR)
477.15
+1.02
(+0.21%)
USD |
NASDAQ |
Feb 13, 12:19
United Therapeutics Cash from Investing (Quarterly) : 140.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Catalyst Pharmaceuticals, Inc. | 0.00 |
| MannKind Corp. | -25.06M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 562.10M |
| Cash from Financing (Quarterly) | -956.00M |
| Free Cash Flow | 1.116B |
| Free Cash Flow Per Share (Quarterly) | 7.317 |
| Free Cash Flow to Equity (Quarterly) | 346.10M |
| Free Cash Flow to Firm (Quarterly) | 348.42M |
| Free Cash Flow Yield | 4.85% |